Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma

Journal of Molecular Endocrinology

Volumn 39, Issue 5-6, 2007, Pages 333-341

  Ishikawa, Hiroshi ^a   Shozu, Makio ^b   Okada, Masahiko ^a   Inukai, Mai ^a   Zhang, Bo ^a   Kato, Keiichi ^a   Kasai, Tadayuki ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC DATABASE; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MYOMETRIUM; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; QUANTITATIVE ANALYSIS; TUMOR GROWTH; UTERUS MYOMA;

BINDING SITES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; PROTEIN BINDING; UTERINE NEOPLASMS; UTERUS;

EID: 38449122035     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-06-0069     Document Type: Article

References (31)

1. Ahn WS, Kim KW, Bae SM, Yoon JH, Lee JM, Namkoong SE, Kim JH, Kim CK, Lee YJ & Kim YW 2003 Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. International Journal of Experimental Pathology 84 267-279.
2. Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS & Toniolo P 2005 Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Human Reproduction 20 852-863.
3. Bae SK, Bae MH, Alan MY, Son MJ, Lee YM, Bae MK, Lee OH, Park BC & Kim KW 1999 Egr-1 mediates transcriptional activation of IGF-2 gene in response to hypoxia. Cancer Research 59 5989-5994.
4. Baek WK, Kim D, Jung N, Yi YW, Kim JM, Cha SD, Bae I & Cho CH 2003 Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. American Journal of Obstetrics and Gynecology 188 634-639.
5. Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM et al. 2001 The early growth response gene EGR-1 behaves as a suppressor gene that Is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clinical Cancer Research 7 2788-2796.
6. Cao X, Mahendran R, Guy GR & Tan YH 1992 Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphospholylation of its gene product. Journal of Biolgical Chemistry 267 12991-12997.
7. Catherino WH, Prupas C, Tsibris JC, Leppert PC, Payson M, Nieman LK & Segars JH 2003 Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertility and Sterility 80 282-290.
8. Chegini N, Verala J, Luo X, Xu J & Williams RS 2003 Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Journal of the Society of Gynecological Investigation 10 161-171.
9. Diaz BV, Lenoir MC, Ladoux A, Frelin C, Demarchez M & Michel S 2000 Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. Journal of Biolgical Chemistry 275 642-650.
10. De Falco M, Staibano S, D'Armiento FP, Mascolo M, Salvatore G, Busiello A, Carbone IF, Pollio F & Di Lieto A 2006 Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-β3 and connective tissue growth factor. Journal of the Society of Gynecological Investigation 13 297-303.
11. Gossen M & Bujard H 1992 Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. PNAS 89 5547-5551.
12. Hoffman PJ, Milliken DB, Gregg LC, Davis RR & Gregg JP 2004 Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertility and Sterility 82 639-649.
13. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D & Adamson ED 1997 Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. International Journal Cancer 72 102-109.
14. Huang RP, Fan Y, deBelle I, Ni Z, Matheny W & Adamson ED 1998 Egr-1 inhibits apoptosis during the u.v. response: correlation of cell survival with Egr-1 phosphorylation. Cell Death and Differentiation 5 96-106.
15. Kasai T, Shozu M, Murakami K, Segawa T, Shinohara K, Nomura K & Inoue M 2004 Increased expression of type I 17β-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma. Journal of Clinical Endocrinology and Metabolism 89 5661-5668.
16. Lee BS & Nowak RA 2001 Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGFβ3) and altered responses to the antiproliferative effects of TGFβ. Journal of Clinical Endocrinology and Metabolism 86 913-920.
17. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J et al. 2004 Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β[1]-induced pulmonary fibrosis. Journal of Experimental Medicine 200 377-389.
18. Liu C, Rangnekar VM, Adamson E & Mercola D 1998 Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Therapy 5 3-28.
19. McCaffrey TA, Fu C, Du B, Eksinar S, Kent KC, Bush H Jr., Kreiger K, Rosengart T, Cybulsky MI, Silverman ES et al. 2000 High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. Journal of Clinical Investigation 105 653-662.
20. Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL & Morton CC 2004 Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes and Cancer 40 97-108.
21. Shin SY, Bahk YY, Ko J, Chung IY, Lee YS, Downward J, Eibel H, Sharma PM, Olefsky JM, Kim YH et al. 2006 Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras. Embo Journal 25 1093-1103.
22. Shozu M, Sumitani H, Segawa T, Yang H-J, Murakami K, Kasai T & Inoue M 2002 Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19): the impact of the human genome on endocrinology: special features. Journal of Clinical Endocrinology and Metabolism 87 2540-2548.
23. Shozu M, Murakami K, Segawa T, Kasai T, Ishikawa H, Shinohara K, Okada M & Inoue M 2004 Decreased expression of early growth response-1 and its role in uterine leiomyoma growth. Cancer Research 64 4677-4684.
24. Skubitz KM & Skubitz AP 2003 Differential gene expression in uterine leiomyoma. Journal of Laboratory and Clinical Medicine 141 297-308.
25. Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP & Pacifici R 1998 Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and Its interaction with Sp-1. Journal of Clinical Investigation 102 1850-1859.
26. Sumitani H, Shozu M, Segawa T, Murakami K, Yang H-J, Shimada K & Inoue M 2000 In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/ intracrine mechanism. Endocrinology 141 3852-3861.
27. Tsibris JC, Segars J, Coppola D, Mane S, Wilbanks GD, O'Brien WF & Spellacy WN 2002 Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertility and Sterility 78 114-121.
28. Vollenhoven BJ, Herington AC & Healy DL 1993 Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. Journal of Clinical Endocrinology and Metabolism 76 1106-1110.
29. Wang H, Mahadevappa M, Yamamoto K, Wen Y, Chen B, Warrington JA & Polan ML 2003 Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertility and Sterility 80 266-276.
30. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ & Rogers PA 2003 Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Molecular Human Reproduction 9 541-549.
31. Wu Y, Zhang Q, Ann DK, Akhondzadeh A, Duong HS, Messadi DV & Le AD 2004 Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. American Journal of Physiology Cell Physiology 286 C905-C912.